Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Buy
+48,305
New +$2.25M 0.01% 1514
2025
Q3
Sell
-121,804
Closed -$5.88M 3602
2025
Q2
$5.88M Buy
+121,804
New +$6.22M 0.03% 465
2024
Q4
Sell
-69,395
Closed -$4M 3168
2024
Q3
$4M Buy
+69,395
New +$3.75M 0.02% 563
2024
Q2
Sell
-21,498
Closed -$1.04M 3032
2024
Q1
$1.04M Buy
+21,498
New +$1.05M 0.01% 865
2023
Q2
Sell
-10,429
Closed -$567K 3219
2023
Q1
$567K Buy
+10,429
New +$507K 0.01% 1276
2022
Q3
Sell
-26,646
Closed -$1.33M 3455
2022
Q2
$1.33M Buy
+26,646
New +$1.41M 0.01% 756
2022
Q1
Sell
-31,776
Closed -$1.59M 3804
2021
Q4
$1.59M Buy
+31,776
New +$1.57M 0.01% 789
2021
Q3
Sell
-99,136
Closed -$5.22M 3718
2021
Q2
$5.22M Buy
+99,136
New +$5.17M 0.05% 298
2020
Q4
Sell
-6,149
Closed -$308K 2417
2020
Q3
$308K Sell
6,149
-28,057
-82% -$1.44M 0.01% 1125
2020
Q2
$1.75M Buy
+34,206
New +$1.66M 0.05% 367

Other funds holding SNY

HRT Financial's SNY Position: Q1 2026 in Review

HRT Financial opened a new position in Sanofi (SNY) in Q1 2026: 48,305 shares worth $2.33M. The stake represents 0.01% of the portfolio and ranks #1514 among its holdings. This is a return to the name: HRT Financial previously reported a position in SNY as recently as Q2 2025.

HRT Financial first reported a position in SNY in Q2 2020 and has held it in 10 quarters since. The position peaked at $5.88M in Q2 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • HRT Financial held 48,305 shares of Sanofi worth $2.33M as of Q1 2026.
  • Sanofi was a new HRT Financial position in Q1 2026.
  • Sanofi made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1514 holding.
  • HRT Financial first reported a position in Sanofi in Q2 2020 and has held it in 10 quarters since.
  • HRT Financial's Sanofi position peaked at $5.88M in Q2 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.